Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Boris Ya. Alekseev"'
Autor:
Maria I. Volkova, Alexey S. Kalpinskiy, Konstantin V. Menshikov, Lilia V. Gorbuleva, Alexander V. Sultanbaev, Olga I. Evsyukova, Varazdat R. Meltonian, Sergey V. Mishugin, Mikhail R. Maturov, Anna S. Olshanskaya, Dmitrii Iu. Shemetov, Tatyana A. Sannikova, Mariia V. Makhnutina, Marina A. Filipieva, Elena A. Gaijsina, Elena G. Ovchinnikova, Ovsep A. Mailian, Boris Ya. Alekseev, Vsevolod B. Matveev
Publikováno v:
Современная онкология, Vol 25, Iss 2, Pp 221-228 (2023)
Aim. To assess the safety and to analyze an influence of cabozantinib monotherapy toxicity on treatment efficacy in unselected Russian patients with metastatic renal cell carcinoma (mRCC). Materials and methods. Medical data of 92 patients with ve
Externí odkaz:
https://doaj.org/article/661c9556c8fd45debb7fe8c15b3a720b
Publikováno v:
Современная онкология, Vol 25, Iss 2, Pp 151-154 (2023)
The results of several completed studies have led to a change in approaches to treating renal cell carcinoma (RCC) and are reflected in the clinical guidelines of the Ministry of Health of Russia and the practical guidelines of the Russian Society of
Externí odkaz:
https://doaj.org/article/83074072a723482ca2aa23de91a7a695
Publikováno v:
Современная онкология, Vol 25, Iss 2, Pp 155-158 (2023)
Guidelines for drug therapy of urothelial cancer (UC) have had several significant updates since new data from clinical studies became available and due to updates of labels for certain drugs approved for this indication in the Russian Federation. Op
Externí odkaz:
https://doaj.org/article/c20a81684eef4e1d8e628f6ef60b1952
Publikováno v:
Современная онкология, Vol 25, Iss 1, Pp 15-20 (2023)
The emergence of new drug therapy regimens and the completion of several large randomized trials led to significant changes in the clinical guidelines of the Ministry of Health of Russia and the practical guidelines of the Russian Society of Clinical
Externí odkaz:
https://doaj.org/article/73e646feed1d4e16af265e5087c75f8b
Autor:
Elena A. Pudova, Anastasiya A. Kobelyatskaya, Irina V. Katunina, Anastasiya V. Snezhkina, Maria S. Fedorova, Vladislav S. Pavlov, Ildar R. Bakhtogarimov, Margarita S. Lantsova, Sergey P. Kokin, Kirill M. Nyushko, Boris Ya. Alekseev, Dmitry V. Kalinin, Nataliya V. Melnikova, Alexey A. Dmitriev, George S. Krasnov, Anna V. Kudryavtseva
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 3
Pages: 2418
Volume 24
Issue 3
Pages: 2418
Radical prostatectomy is the gold standard treatment for prostate cancer (PCa); however, it does not always completely cure PCa, and patients often experience a recurrence of the disease. In addition, the clinical and pathological parameters used to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e794f4c3f9ab396e7383e9a75746525e
https://doi.org/10.3390/ijms24032418
https://doi.org/10.3390/ijms24032418